医学
安慰剂
抗坏血酸
化疗
内科学
维生素
癌症
维生素C
性能状态
胃肠病学
外科
病理
食品科学
化学
替代医学
作者
Edward T. Creagan,Charles G. Moertel,Judith Rich O'Fallon,Allan J. Schutt,Michael J. O’Connell,Joseph Rubin,Stephen Frytak
标识
DOI:10.1056/nejm197909273011303
摘要
One hundred and fifty patients with advanced cancer participated in a controlled double-blind study to evaluate the effects of high-dose vitamin C on symptoms and survival. Patients were divided randomly into a group that received vitamin C (10 g per day) and one that received a comparably flavored lactose placebo. Sixty evaluable patients received vitamin C and 63 received a placebo. Both groups were similar in age, sex, site of primary tumor, performance score, tumor grade and previous chemotherapy. The two groups showed no appreciable difference in changes in symptoms, performance status, appetite or weight. The median survival for all patients was about seven weeks, and the survival curves essentially overlapped. In this selected group of patients, we were unable to show a therapeutic benefit of high-dose vitamin C treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI